.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Professor Asisa Volz

Hannover / DE

University of Veterinary Medicine Hannover

Vortrag

27.03.2024
09:30 – 09:45 12 Min. 3 Min.
Abstract talk
O 074
Development of an attenuated Mpox virus for use in improved diagnostics
Clinical and diagnostic virology

Weitere Beteiligungen

25.03.2024
Poster
P 026
MVA-based therapeutic approaches against equine hepacivirus infections in horses
Emerging viruses
25.03.2024
Poster
P 388
Scent dogs identify SARS-CoV-2-infections in respiratory samples from ferrets and hamsters
Clinical and diagnostic virology
25.03.2024
Poster
P 143
Impact of heterologous MVA-booster vaccination on SARS-CoV-2 specific immune responses in a Golden Syrian Hamster model for Coronavirus disease 2019 (COVID-19)
Vaccines
25.03.2024
Poster
P 137
Rapid protective MVA-SARS-2-ST vaccination induces robust T cell responses against SARS-CoV-2 in Syrian hamsters
Vaccines
25.03.2024
Poster
P 136
Single MVA-SARS-2-ST/N vaccination rapidly protects K18-hACE mice against a lethal SARS-CoV-2 challenge infection
Vaccines
25.03.2024
16:00 – 16:15 12 Min. 3 Min.
Abstract talk
O 002
A preclinical model for human mpox disease using skin scarification in CAST/Eij mice
Emerging viruses
25.03.2024
18:00 – 18:15 12 Min. 3 Min.
Abstract talk
O 020
Protective MVA-ST vaccination robustly activates T Cells and antibodies in an Aged-Hamster model for COVID-19
Vaccines
27.03.2024
09:30 – 09:45 12 Min. 3 Min.
Abstract talk
O 074
Development of an attenuated Mpox virus for use in improved diagnostics
Clinical and diagnostic virology